Open Label Trial to Establish the Equivalence Between ANDY-Disc® and Ultrabag® in Patients on CAPD.

PHASE4CompletedINTERVENTIONAL

Enrollment

264

Participants

Timeline

Start Date

May 31, 2002

Study Completion Date

May 31, 2004

Conditions

Chronic Renal Failure

Interventions

DEVICE

Baxter's UltraBag® and FMC Andy·Disc®

Trial Locations (6)

Department of Medicine, Sultanah Aminah Hospital, Johor Bharu

Department of Nephrology, Kuala Lumpur Hospital, Kuala Lumpur

Department of Pediatrics, Kuala Lumpur Hospital, Kuala Lumpur

Department of Medicine, Seremban Hospital, Seremban

Department of Medicine, Penang Hospital, George Town

Department of Nephrology,Selayang Hospital, Selayang Baru Utara

All Listed Sponsors

collaborator

Fresenius Medical Care North America

INDUSTRY

collaborator

Baxter Healthcare Corporation

INDUSTRY

lead

Ministry of Health, Malaysia

OTHER_GOV

NCT00255619 - Open Label Trial to Establish the Equivalence Between ANDY-Disc® and Ultrabag® in Patients on CAPD. | Biotech Hunter | Biotech Hunter